Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0AVMXZ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
HER2-26
|
|||||
| Synonyms |
HER2-26
Click to Show/Hide
|
|||||
| Organization |
Merck & Co. Inc.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
2
|
|||||
| Structure |
|
|||||
| Antibody Name |
Trastuzumab
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (ERBB2)
|
Antigen Info | ||||
| Payload Name |
Tolllike receptor 7/8 agonist 18
|
Payload Info | ||||
| Therapeutic Target |
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Site-specific bioconjugation microbial biotin ligase bioorthogonal.
|
|||||